Skip to main content
. 2022 Sep 16;26(4):295–318. doi: 10.4103/2230-8210.356236

Table 6.

Endocrine evaluation in a patient with obesity

Gland Prevalence in obesity When to assess First diagnostic procedure Other mandatory workup in obesity Not recommended in obesity
Thyroid Severe hypothyroidism is rare but subclinical hypothyroidism is common Thyroid function should be tested in all patients with clinical suspicion of hypothyroidism, those having resistant obesity, and those undergoing procedures for weight loss TSH Free T4 and antibodies (anti-TPO) should be measured only if TSH is elevated Routine FT3 in patients with elevated TSH;
Routine ultrasound of the thyroid gland (irrespective of thyroid function)
Adrenal Cushing’s disease or Cushing’s syndrome is rare Central obesity;
Hypertension;
Classic striae
Facial plethora;
Proximal myopathy;
Purpura
1 mg ODST 24-hr urine cortisol or late-night salivary cortisol in patients with positive 1 mg overnight dexamethasone suppression test;
Imaging (find the cause/source) and ACTH in patients with confirmed hypercortisolism
Routine testing for hypercortisolism
Drug-induced adrenal dysfunction (e.g., glucocorticoids) is common Biochemical testing should be performed in patients with clinical suspicion of hypercortisolism; those undergoing bariatric surgery, or having psychiatric disorders 8 am cortisol Testing for hypercortisolism in patients using corticosteroids
Male gonad Androgen deficiency is common Severe obesity;
Symptoms and signs of hypogonadism
LH, FSH, fasting morning testosterone Total and free testosterone (or calculated), SHBG in patients with clinical features of hypogonadism Routine biochemical testing for hypogonadism
unless key clinical symptoms or signs of hypogonadism
Female gonad Androgen excess is common Central obesity;
Irregular menses;
Hirsutism;
Acanthosis nigricans chronic anovulation/infertility
LH, FSH, estradiol, testosterone Total testosterone, SHBG, Δ 4androstenedione, 17-hydroxyprogesterone and prolactin in patients with menstrual irregularities (assess in early follicular phase if menstrual cycle is predictable) Routine testing for gonadal dysfunction
Clinical features of PCOS Total testosterone, free T, Δ 4androstenedion, SHBG and blood glucose Ovarian morphology
Pituitary GH deficiency is rare Hypothalamic or pituitary disease, pituitary or hypothalamic
surgery or radiation therapy
IGF1/GH using a dynamic test only in patients with suspected hypopituitarism Routine testing for IGF1/GH
Hypopituitarism is rare Suspicion of hypothalamic obesity;
Surgery or radiotherapy in pituitary region
FT4 TSH LH FSH (testosterone or estradiol);
GH IGF-1 PRL;
ACTH stimulation test;
GH stimulation test
Acquired hypothalamic obesity (hypothalamic lesions or, tumors) is rare Severe hyperphagia;
Possible multiple endocrine abnormalities
Brain CT/MRI
Parathyroid Pseudohypoparathyroidism type 1a (Albright hereditary osteodystrophy) is rare Short stature, short fourth metacarpal bones, obesity, s.c. calcifications, developmental delay PTH↑calcium↓phosphate ↑ Routine testing for hyperparathyroidism or Vitamin D deficiency
Syndromic obesity Hypothalamic obesity associated with Genetic Syndromes is very rare Hypogonadism (hypogonadism or hypergonadotropic) or variable gonadal function; dysmorphic syndrome, mental and grow retardation Leptin (leptin resistance); genetic testing Routine testing of hormones such as leptin and ghrelin in patients with suspicion of syndromic obesity

Abbreviations: ACTH, Adrenocorticotropic hormone; FSH, Follicle-stimulating hormone; FT4, Free thyroxine; GH, Growth hormone; IGF, Insulin-like growth factor; LH, Luteinizing hormone; MC4R, Melanocortin receptor 4; ODST, Overnight dexamethasone suppression test; PCSK, Proprotein convertase subtilisin/kexin; PTH, Parathyroid hormone; TSH, Thyroid-stimulating hormone